Two Ebola patients ‘cured’ by new drugs in Democratic Republic of Congo

Doctors in the Democratic Republic of Congo say that two Ebola patients who were treated with new drugs in Goma have been declared “cured”.

Two Ebola patients ‘cured’ by new drugs in Democratic Republic of Congo

Doctors in the Democratic Republic of Congo say that two Ebola patients who were treated with new drugs in Goma have been declared “cured”.

Doctors fighting Ebola quickly used the case on Tuesday to press the message that people with Ebola can recover if they seek proper care.

Dr Jean-Jacques Muyembe, director of DR Congo’s National Institute for Biomedical Research, said Ebola is dangerous but it is also curable with proper treatment.

Dr Muyembe said two new drugs are now being used to treat Ebola patients because tests have shown they are effective.

He said there is less danger that Ebola will spread through Goma, the capital of North Kivu province with more than two million inhabitants, because about 200 contacts and suspected cases have been identified and have received proper medication.

more courts articles

DUP calls for measures to prevent Northern Ireland from becoming 'magnet' for asylum seekers DUP calls for measures to prevent Northern Ireland from becoming 'magnet' for asylum seekers
UK's Illegal Migration Act should be disapplied in Northern Ireland, judge rules UK's Illegal Migration Act should be disapplied in Northern Ireland, judge rules
Former prisoner given indefinite hospital order for killing Irishman in London Former prisoner given indefinite hospital order for killing Irishman in London

More in this section

Benny Gantz Israel War Cabinet member threatens to quit government unless new plan adopted
Armed robbers hit luxury store in Paris reported to be ‘jeweller to the stars’ Armed robbers hit luxury store in Paris reported to be ‘jeweller to the stars’
Aid from new pier off Gaza should be distributed this weekend Aid from new pier off Gaza should be distributed this weekend
Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited